All Stories

  1. 2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Pericles Calias